URINARY HOST IMMUNE RESPONSE BIOMARKERS IN URINARY TRACT INFECTIONS: ASSOCIATIONS WITH URINE CULTURE AND CLINICAL OUTCOMES

Authors

  • Irina Valeryevna Egorova Author
  • Armen Gaykovich Sargsyan Author
  • Lana Ambergovna Gogilava Author
  • Aleksei Vladimirovich Osipenko Author
  • Amina Shamilievna Balasieva Author
  • Samira Muslimovna Bakrieva Author

DOI:

https://doi.org/10.4238/kr25hc29

Keywords:

urinary tract infection; urine culture; host response; cytokines; interleukin-8; lipocalin-2; recurrence; biomarkers.

Abstract

Objective. To examine associations of urinary host immune response proteins with urine culture, symptomatic urinary tract infection diagnosis, and subsequent clinical outcomes in adults. Methods. Available full texts were critically appraised within a prespecified protocol. PubMed, eLibrary, ClinicalTrials.gov and WHO ICTRP were searched, with targeted full text retrieval and reference checking. Scopus and Web of Science searches could not be performed; Cochrane records could not be exported and Google Scholar access was blocked. Of 4,778 combined records, 238 cross-database duplicates were automatically merged. Screening of the remaining 4,540 records is incomplete; this manuscript does not represent a completed systematic review. Results. Eleven core full-text reports were examined across nine report families. Three reports shared the same symptomatic sample. Diagnostic performance varied with the population and reference definition. Diagnostic discrimination did not establish prediction of recurrence. Serial biomarker changes were distinguished from baseline prognostic associations. Aggregate-data reanalysis of one selected sample gave 84.0% sensitivity and 91.2% specificity for the ≥2-marker rule. These are study-specific estimates, not pooled results. Conclusion. Urinary immune response proteins may complement microbiological testing, but the assessed evidence does not establish a universal threshold or a validated standalone predictor of treatment failure. External validation and evaluation of incremental clinical value are required.

Downloads

Published

2026-11-04

Issue

Section

Articles